|
3.1 Prévention - Tabac
|
|
|
|
3.1.1 Prévention - Tabac - e-cigs
|
|
|
|
|
3.7 Prévention - Alcool
|
|
|
Pills prescribed for alcoholism might not work, study finds [The Guardian]
|
|
|
|
|
|
None
of the five drugs has a body of reliable evidence behind it, say the
scientists, even though one of the drugs, nalmefene, has been approved
for use in the NHS by Nice, the National Institute for Health and Care
Excellence. Another, baclofen, has generated huge excitement, especially
in France, but has been linked to deaths.
|
|
|
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
New toolkit helps nurses use genomics in patient care [NIH]
|
|
|
|
|
|
Developed
with input from clinical educators and administrators, the Method for
Introducing a New Competency Genomics (MINC) website provides resources
for nursing leaders at all levels of genomics competency, ranging from
basic knowledge about genomics to its practical impact on healthcare
systems and policies.
| |
|
|
|
4.7 Dép., diag. & prono. - Col de l'utérus
|
|
|
|
5. Traitements
|
|
|
Alnylam Breaks Through [In the Pipeline]
|
|
|
|
|
|
The
problems of drug delivery and stability are some of the big reasons
it’s taken so long to get to this point (the same goes for all
oligonucleotide ideas), and even now they represent serious limitations.
|
|
|
|
|
|
|
|
5.1 Traitements - Pré-clinique
|
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
FDA’s Janet Woodcock: the clinical trials system is ‘broken’ [EndPoints]
|
|
|
|
|
|
The
comment came at the end of Woodcock’s talk in which she also noted that
use of master protocols (protocols for trials that look at multiple
therapies in a single disease or a single treatment in multiple
diseases) and the development of new clinical trial networks “need to be
the future.”
|
|
|
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.1 Immunothérapies - partenariats
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
FDA Approval of Tisagenlecleucel [JAMA Oncology]
|
|
|
|
|
|
The
science underlying chimeric antigen receptor T cells (CAR-T) heralds a
new era of treatment, and the list price of $475 000 for the new drug
(delivered as a one-time infusion) definitively shattered oncology drug
pricing norms.
|
|
|
|
|
|
|
5.12.6 Immunothérapies - AMM
|
|
|
|
5.5 ASCO
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.10 Politiques
|
|
|
UK science seeks ‘a new and special relationship with the EU’ [Science]
|
|
|
|
|
|
Well
if you look at the paper that we put out [on 6 September], that makes
it very clear that we see enormous value from European collaboration.
And that we will be keen to put in place a new and special relationship
with the EU that will make that possible and something that we can even
build on and develop in years to come.
|
|
|
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
6.5 Médecines alternatives
|
|
|
|
|
6.7.2 Applis
|
|
|
|
6.8 Communication
|
|
|